Thirty-one transcripts were found to be upregulated in CML CD34+CD38−ALDHhigh cells compared to normal CD34+CD38−ALDHhigh or CD34+CD38+ cells (Figure 2A), representing selective putative CML stem cell targets. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.